Category: General autoimmunity

F.52 - Clinical Data Specification and Coding for Cross-analyses with Omics Data in Autoimmune Diseases’ Trials

Friday, Jun 16
6:15 PM – 7:30 PM

Caroline Aheng

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

Olivier Benveniste

APHP, Hôpital Pitié-Salpêtrière, Internal Medecine, Paris, France
Paris, Ile-de-France, France

Francis Berenbaum

APHP, Hôpital Saint-Antoine, Rheumatology Department, Inserm UMR S_938, UPMC Univ Paris 06, Paris, France
Paris, Ile-de-France, France

Claude Bernard

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

Bahram Bodaghi

APHP, Hôpital Pitié-Salpêtrière, Ophthalmology, F-75651, Paris, France
Paris, Ile-de-France, France

Patrice Cacoub

APHP, Hôpital Pitié-Salpêtrière, Internal Medecine and Clinical Immunology
Paris, Ile-de-France, France

Maeva Cordoba

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

Iannis Drakos

Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), F-75005, Paris, France
Paris, Ile-de-France, France

Gilles Grateau

APHP, Hôpital Tenon, Internal Medecine, Paris, France
Paris, Ile-de-France, France

Agnes Hartemann

APHP, Hôpital Pitié-Salpêtrière, Diabetology, F-75651, Paris, France
Paris, Ile-de-France, France

David Klatzmann

Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), F-75005, Paris, France
Paris, Ile-de-France, France

Roberta Lorenzon

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

Claire Ribet

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

Michelle Rosenzwagj

AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (I2B), F-75651, Paris, France
Paris, Ile-de-France, France

David Saadoun

APHP, Hôpital Pitié-Salpêtrière, Internal Medecine and Clinical Immunology
Paris, Ile-de-France, France

Philippe Seksik

APHP, Hôpital Saint-Antoine, Gastroenterology Department, Paris, France
Paris, Ile-de-France, France

Jeremie Sellam

APHP, Hôpital Saint-Antoine, Rheumatology Department, Inserm UMR S_938, UPMC Univ Paris 06, Paris, France
Paris, Ile-de-France, France

Adrien Six

Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), F-75005, Paris, France
Paris, Ile-de-France, France

Encarnita Mariotti-Ferrandiz

Associate Professor
Sorbonne Université, UPMC Univ Paris 06, UMRS 959, Immunology-Immunopathology-Immunotherapy (I3), F-75005, Paris, France
Paris, Ile-de-France, France